Tesaglitazar

Anti-TYR tyrosinase, 25ul UN 1687 6.1 PG2

Biochem/physiol Actions Tazarotene is transformed to tazarotenic acid with the help of esterases. Tazarotenic acid regulates the pathogenic aspects of psoriasis through normalizing abnormal keratinocyte differentiation.

Biochem/physiol Actions Tesaglitazar is a potent and specific dual PPAR&#945:/&#947: agonist that improves insulin resistance and carbohydrate and lipid metabolism in ob/ob mice and obese Zucker rats.

Biochem/physiol Actions Tesaglitazar is a potent and specific dual PPAR&#945:/&#947: agonist that improves insulin resistance and carbohydrate and lipid metabolism in ob/ob mice and obese Zucker rats.

A dual agonist of PPAR&alpha and &gamma (IC₅₀s = 1 and 0.2 &microM, respectively) that at 3 &microM/kg/day for 3 weeks has been used to reduce insulin resistance in obese Zucker rats.

A dual agonist of PPAR&alpha and &gamma (IC₅₀s = 1 and 0.2 &microM, respectively) that at 3 &microM/kg/day for 3 weeks has been used to reduce insulin resistance in obese Zucker rats.

A dual agonist of PPAR&alpha and &gamma (IC₅₀s = 1 and 0.2 &microM, respectively) that at 3 &microM/kg/day for 3 weeks has been used to reduce insulin resistance in obese Zucker rats.

A dual agonist of PPAR&alpha and &gamma (IC₅₀s = 1 and 0.2 &microM, respectively) that at 3 &microM/kg/day for 3 weeks has been used to reduce insulin resistance in obese Zucker rats.

Tetrahydro-2-(7-octyn-1-yloxy)-2H-pyran.

A major urinary metabolite of PGF2&alpha.

Biochem/physiol Actions TPA023 is a highly potent, functionally selective agonist for &#945:2-, &#945:3-, and &#945:5GABAA receptors that shows zero efficacy at a1GABAA subtypes. TPA023 exhibits anxiolytic and anticonvulsant effects in both

Biochem/physiol Actions TPA023 is a highly potent, functionally selective agonist for &#945:2-, &#945:3-, and &#945:5GABAA receptors that shows zero efficacy at a1GABAA subtypes. TPA023 exhibits anxiolytic and anticonvulsant effects in both